See more : Moringa Acquisition Corp (MACAU) Income Statement Analysis – Financial Results
Complete financial analysis of Legacy Technology Holdings, Inc. (LTHO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Legacy Technology Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Adeunis Société anonyme (ALARF.PA) Income Statement Analysis – Financial Results
- LAMEDITECH Co., Ltd. (462510.KQ) Income Statement Analysis – Financial Results
- Formosa Optical Technology Co.,Ltd. (5312.TWO) Income Statement Analysis – Financial Results
- Xilinx, Inc. (XIX.DE) Income Statement Analysis – Financial Results
- President Automobile Industries Public Company Limited (PACO.BK) Income Statement Analysis – Financial Results
Legacy Technology Holdings, Inc. (LTHO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.genomics-giws.com
About Legacy Technology Holdings, Inc.
Legacy Technology Holdings, Inc. develops and commercializes a web-based genomic preventative medicine and medical software solution. It uses algorithms to analyze data on individual patient lifestyle factors, such as blood tests, biometrics, diet, environmental, nutraceutical, pharmaceutical, and genetic makers. The company was incorporated in 2012 and is based in Arvada, Colorado .
| Metric | 2020 | 2019 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 36.79K | 2.67K |
| Other Expenses | -63.83K | 0.00 |
| Operating Expenses | 100.62K | 2.67K |
| Cost & Expenses | 100.62K | 2.67K |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | 22.42K | 2.74K |
| Depreciation & Amortization | 206.30K | 171.86K |
| EBITDA | -100.62K | -2.67K |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -100.62K | -2.67K |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | -22.42K | -2.74K |
| Income Before Tax | -123.04K | -5.41K |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 |
| Net Income | -123.04K | -5.41K |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 |
| Weighted Avg Shares Out | 72.70M | 72.70M |
| Weighted Avg Shares Out (Dil) | 72.70M | 72.70M |
Source: https://incomestatements.info
Category: Stock Reports